患者血液管理の市場規模、シェア、成長分析：製品別、コンポーネント別、エンドユーザー別、地域別 - 産業予測 2024～2031年

患者血液管理市場規模は2023年に137億9,000万米ドルと評価され、2024年の146億6,000万米ドルから2032年には239億米ドルに成長し、予測期間（2025～2032年）のCAGRは6.30%で成長する見通しです。

世界の患者血液管理（PBM）市場は、慢性疾患の有病率の上昇、外科手術の増加、PBMの利点に対する意識の高まりに後押しされ、力強い成長軌道に乗っています。この戦略的アプローチは、輸血を必要とする患者のケアを強化し、最終的に転帰を改善し、輸血への依存を最小限に抑えることを目的としています。心血管障害、がん、血液疾患などの慢性疾患は、輸血の必要性を高める外科手術の主な原因となっています。しかし、ヘルスケアプロバイダーは、感染症や免疫反応などの関連リスクを軽減するために、PBM戦略を実施するようになってきています。このシフトは、手術結果の改善と合併症の減少に重点を置いており、PBMソリューションの市場需要を促進しています。さらに、輸血に代わる革新的な選択肢に対する認識が高まっており、世界規模でPBMの導入が進んでいます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

患者血液管理市場規模：製品別

• 市場概要
• 機器
• 血液処理装置
  • 遠心
  • 血液細胞処理装置
• 輸血機器
  • アフェレーシス装置
  • 細胞救済システム
• 血液培養スクリーニング装置
  • 自動血液培養システム
  • サポート機器
• 診断および検査機器
  • ポリメラーゼ連鎖反応
  • 血液分析装置
  • 血液型検査装置
  • 次世代シーケンシング（NGS）プラットフォーム
  • その他
• 血液保存装置
  • 冷蔵庫
  • 冷凍庫
• アクセサリー
• 注射器と針
• バイアルとチューブ
• 血液バッグ
• その他のアクセサリー
• 試薬とキット
• 文化メディア
• 血液型判定試薬
• スライド染色
• アッセイキット
• その他
• ソフトウェア
• 血液銀行および輸血ソフトウェア
• その他

患者血液管理市場規模：コンポーネント別

• 市場概要
• 全血
• 血液成分

患者血液管理市場規模：エンドユーザー別

• 市場概要
• 病院
• 血液銀行

患者血液管理市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Haemonetics Corporation（USA）
• Macopharma（France）
• Terumo Corporation（Japan）
• B. Braun SE（Germany）
• Grifols, S.A.（Spain）
• Asahi Kasei Corporation（Japan）
• BioMerieux SA（France）
• LivaNova PLC（UK）
• Fresenius Kabi AG（Germany）
• Roche Holding AG（Switzerland）
• Abbott Laboratories（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Danaher Corporation（USA）
• Siemens Healthineers（Germany）
• Johnson & Johnson（USA）
• Medtronic plc.（Ireland）
• BD（Becton, Dickinson and Company）（USA）
• Cardinal Health（USA）
• Teleflex Incorporated（USA）
• Stryker Corporation（USA）

結論と推奨事項

Patient Blood Management Market size was valued at USD 13.79 Billion in 2023 and is poised to grow from USD 14.66 Billion in 2024 to USD 23.9 Billion by 2032, growing at a CAGR of 6.30% during the forecast period (2025-2032).

The global patient blood management (PBM) market is on a robust growth trajectory, fueled by rising chronic disease prevalence, an uptick in surgical procedures, and heightened awareness of PBM benefits. This strategic approach aims to enhance care for patients needing blood transfusions, ultimately improving outcomes and minimizing transfusion reliance. Chronic diseases like cardiovascular disorders, cancer, and blood disorders are major contributors to surgical needs, intensifying transfusion requirements. However, healthcare providers are increasingly implementing PBM strategies to mitigate associated risks such as infections and immune reactions. This shift emphasizes improving surgical results and reducing complications, propelling market demand for PBM solutions. Furthermore, awareness of innovative alternatives to transfusions is increasingly promoting the adoption of PBM practices on a global scale.

Top-down and bottom-up approaches were used to estimate and validate the size of the Patient Blood Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Patient Blood Management Market Segmental Analysis

Global Patient Blood Management Market is segmented by product, component, end user and region. Based on product, the market is segmented into instruments, blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, blood storage devices, accessories, syringes & needles, vials & tubes, blood bags, other accessories, reagents and kits, culture media, blood typing reagents, slide staining, assay kits, others, software, blood bank and transfusion software and others. Based on component, the market is segmented into whole blood and blood components. Based on end user, the market is segmented into hospitals and blood banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Patient Blood Management Market

The Patient Blood Management market is driven by significant advancements in transfusion medicine, which have transformed the landscape of blood management practices. Innovations in techniques and technologies have greatly enhanced the safety, efficiency, and effectiveness of blood transfusions. As a result, healthcare providers are increasingly embracing patient blood management strategies to optimize patient outcomes. These developments not only reduce the risks associated with transfusions but also foster a greater understanding of the importance of prudent blood usage. Consequently, the ongoing evolution in transfusion medicine is playing a pivotal role in propelling the growth of the Patient Blood Management market.

Restraints in the Patient Blood Management Market

The Patient Blood Management market faces several restraints, primarily due to the challenges associated with altering established transfusion practices. Transitioning towards these new management strategies requires a significant shift away from traditional methods and medical standards. This shift can be hindered by resistance to change from healthcare professionals, as well as the need to accommodate individual physician preferences. Moreover, ensuring that adequate training and education are provided to facilitate understanding and acceptance of these innovative practices poses additional hurdles. As a result, these factors collectively impede the broader implementation and acceptance of patient blood management methodologies in clinical settings.

Market Trends of the Patient Blood Management Market

In the global Patient Blood Management market, a notable trend is the heightened emphasis on personalized and evidence-based transfusion practices, driven by a growing awareness of the risks associated with indiscriminate blood use. Healthcare providers are increasingly adopting tailored transfusion strategies that align with individual patient needs and clinical conditions, steering away from the traditional one-size-fits-all approach. This shift not only aims to enhance patient safety by reducing the likelihood of transfusion reactions and infections but also seeks to lower healthcare costs through optimized blood utilization. Consequently, hospitals and healthcare systems are investing in technologies and training that support this patient-centric model, indicating a transformational shift in blood management practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Patient Blood Management Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Blood Processing Devices
  • Centrifuge
  • Blood Cell Processors
• Blood Transfusion Devices
  • Apheresis Machines
  • Cell Salvage Systems
• Blood Culture Screening Devices
  • Automated Blood Culture Systems
  • Supporting Equipment
• Diagnostic & Testing Instruments
  • Polymerase Chain Reaction
  • Hematology Analyzer
  • Blood Grouping Analyzers
  • Next-Generation Sequencing (Ngs) Platforms
  • Others
• Blood Storage Devices
  • Refrigerator
  • Freezers
• Accessories
• Syringes & Needles
• Vials & Tubes
• Blood Bags
• Other Accessories
• Reagents And Kits
• Culture Media
• Blood Typing Reagents
• Slide Staining
• Assay Kits
• Others
• Software
• Blood Bank And Transfusion Software
• Others

Global Patient Blood Management Market Size by Component & CAGR (2025-2032)

• Market Overview
• Whole Blood
• Blood Components

Global Patient Blood Management Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Blood Banks

Global Patient Blood Management Market Size & CAGR (2025-2032)

• North America (Product, Component, End User)
  • US
  • Canada
• Europe (Product, Component, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Component, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Component, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Component, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Haemonetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc. (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations